Delivery Order SPE2DB22D1017-SPE2DB25FF9TW
Award Date
4/10/25
Potential Completion Date
4/11/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,472.74, is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication. The delivery order has a firm fixed price and an ultimate completion date of April 11, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $9,292.54 and a performance period through August 19, 2024. The contract is a firm-fixed-price type and does not have a set-aside designation. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a prescription medication, with a ceiling value of $17,732.62 and a performance period through April 16, 2025. The contract is not set-aside and was competed openly. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used in the treatment of diabetes. The contract has a ceiling value of $2,224.83 and a period of performance through March 31, 2025. There is no set-aside designation indicated for this award. This delivery order is issued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $5,107.01 and a period of performance through March 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $4,996.75 and a period of performance through February 25, 2025. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product, with a ceiling value of $3,190.20 and a completion date of April 7, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen also holds a larger Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,260.76, is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used for healthcare purposes. The contract has an ultimate completion date of January 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order under a $999,999,999 Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order is for NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product, with a ceiling value of $1,582.60. The contract has a period of performance through April 2, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product used for the treatment of diabetes. The delivery order has a firm fixed price of $1,562.78 and a completion date of October 14, 2022. The contract is not designated with a set-aside requirement, indicating open competition....